News 15 mai 2024 Allegria Therapeutics raises 3.5 million dollars in seed financing round Allegria Therapeutics has received seed funding of 3.5 million dollars from the founding investor Forty51 Ventures. The biotech startup is develo...
Aktuell 15 mai 2024 Allegria Therapeutics nimmt 3,5 Millionen Dollar in Seed-Runde ein Allegria Therapeutics hat eine Seed-Finanzierung von 3,5 Millionen Dollar durch den Gründungsinvestor Forty51 Ventures erhalten. Das Biotech-Star...
Fact Sheet 10 abr 2024 Find out more about opportunities for imported processed food in Indonesia The total market size of Indonesia’s imported processed food is estimated to reach 19.4 billion USD in 2024. The country offers increasing busine...
News 22 mai 2024 CUTISS secures 25 million Swiss francs from investors CUTISS has closed a first Series C financing round in the amount of 25 million Swiss francs. With this, the life sciences company with a focus on...
Factsheet 10 abr 2024 Erfahren Sie mehr über den Markt für verarbeitete Lebensmittel in Indonesien Der indonesische Markt für ausländische verarbeitete Lebensmittel wird 2024 geschätzte 19,4 Mrd. US-Dollar erreichen. Das Land bietet zunehmende ...
News 01 mar 2024 Idorsia enters collaboration with Viatris The biotech company Idorsia from the canton of Basel-Landschaft and the North American pharmaceutical company Viatris are collaborating on the de...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Fiches d’information 10 abr 2024 Opportunités dans l’importation d’aliments transformés en Indonésie Le marché des aliments transformés importés en Indonésie pèse environ 19,4 milliards USD. Le pays offre des opportunités commerciales croissantes...
Factsheet 10 abr 2024 Opportunità nell’importazione di alimenti trasformati in Indonesia Il mercato degli alimenti trasformati importati in Indonesia vale circa 19,4 miliardi di dollari. Il Paese offre crescenti opportunità commercial...
News 03 mai 2024 Basel research paves way for new drugs Chemists at the University of Basel have developed a new synthesis approach to artificially create terpenes. These contain substances that can be...
Success stories 23 abr 2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
Aktuell 01 mar 2024 Idorsia vereinbart Kooperation mit Viatris Das Biotech-Unternehmen Idorsia und der nordamerikanische Pharmakonzern Viatris arbeiten bei der Entwicklung zweier Phase 3-Medikamente von Ido...
Exemples de Réussite 02 mai 2024 Comment BeiGene favorise l’accès au traitement du cancer à l’échelle mondiale Depuis son siège européen à Bâle, en Suisse, BeiGene collabore de manière stratégique avec des parties prenantes dans le monde entier pour f...
News 10 abr 2024 Empa researchers develop cellulose-based aerogel A laboratory at the Swiss Federal Laboratories for Materials Science and Technology (Empa) has developed an ultralight, biodegradable and printab...
Fact Sheet 04 abr 2024 Energy sector in Guatemala Guatemala has a small energy market, but is experiencing the effects of the energy transition. The sector is demanding technology to keep up with...